Synspire Pharmaceuticals is focused on developing a portfolio of pulmonary products. Inspired by patients and frustrated by the limitations of conventional treatments, Synspire is advancing SNSP113 in order to provide better clinical outcomes and reduce treatment burden in Progressive Pulmonary Disease and acute pulmonary conditions.
We are dedicated to improving the lives of patients and caregivers by providing novel treatments that can be easily incorporated into their lives with the goal of making a profound improvement in their condition.
Learn more about SNSP113 on our Product Development page.
We are inspired by patients and are driven to make a difference.
